Cilostazol combined with P2Y(12) receptor inhibitors: A substitute antiplatelet regimen for aspirin‐intolerant patients undergoing percutaneous coronary stent implantation

BACKGROUND: Cilostazol combined with P2Y(12) receptor inhibitor has been used as a substitute regimen for aspirin‐intolerant patients undergoing percutaneous coronary stent implantation on a small scale. Its exact impact on platelet functions and clinical benefits of aspirin‐intolerant patients is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yikai, Zhou, Peng, Gao, Wen, Zhong, Haoxuan, Chen, Yufei, Chen, Wei, Waresi, Maieryemu, Xie, Kun, Shi, Haiming, Gong, Hui, He, Guibin, Qiu, Zhaohui, Luo, Xinping, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860475/
https://www.ncbi.nlm.nih.gov/pubmed/35120275
http://dx.doi.org/10.1002/clc.23787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860475/
https://www.ncbi.nlm.nih.gov/pubmed/35120275
http://dx.doi.org/10.1002/clc.23787

Ejemplares similares